Stock Analysis
- Hong Kong
- /
- Food and Staples Retail
- /
- SEHK:759
CEC International Holdings Full Year 2024 Earnings: HK$0.045 loss per share (vs HK$0.074 profit in FY 2023)
CEC International Holdings (HKG:759) Full Year 2024 Results
Key Financial Results
- Revenue: HK$1.47b (down 13% from FY 2023).
- Net loss: HK$29.8m (down by 160% from HK$49.6m profit in FY 2023).
- HK$0.045 loss per share (down from HK$0.074 profit in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
CEC International Holdings' share price is broadly unchanged from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 2 warning signs for CEC International Holdings that you should be aware of.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SEHK:759
CEC International Holdings
An investment holding company, retails food and beverage, and household and personal care products in the People’s Republic of China and internationally.
Excellent balance sheet and good value.